U.S. patent number 8,664,192 [Application Number 13/414,084] was granted by the patent office on 2014-03-04 for mutator activity induced by microrna-155 (mir-155) links inflammation and cancer. This patent grant is currently assigned to The Ohio State University. The grantee listed for this patent is Carlo M. Croce. Invention is credited to Carlo M. Croce.
United States Patent | 8,664,192 |
Croce | March 4, 2014 |
Methods of reducing spontaneous mutation rate of a cell in a subject in need thereof by reducing endogenous levels of miR-155 are described.
Inventors: | Croce; Carlo M. (Columbus, OH) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Applicant: |
|
||||||||||
Assignee: | The Ohio State University
(Columbus, OH) |
||||||||||
Family ID: | 46798544 | ||||||||||
Appl. No.: | 13/414,084 | ||||||||||
Filed: | March 7, 2012 |
Document Identifier | Publication Date | |
---|---|---|
US 20130065938 A1 | Mar 14, 2013 | |
Application Number | Filing Date | Patent Number | Issue Date | ||
---|---|---|---|---|---|
61449854 | Mar 7, 2011 | ||||
Current U.S. Class: | 514/44A; 435/6.1 |
Current CPC Class: | C12N 15/1135 (20130101); C12N 5/0693 (20130101); A61K 31/713 (20130101); A61K 31/7088 (20130101); C12N 15/113 (20130101); A61P 29/00 (20180101); A61P 35/00 (20180101); C12N 2310/113 (20130101); C12N 2310/533 (20130101); C12N 2501/65 (20130101); C12N 2320/30 (20130101); C12N 2310/141 (20130101) |
Current International Class: | C12N 15/11 (20060101); C12Q 1/68 (20060101) |
4172124 | October 1979 | Koprowski et al. |
4196265 | April 1980 | Koprowski et al. |
4608337 | August 1986 | Croce |
4693975 | September 1987 | Kozbor et al. |
4701409 | October 1987 | Croce |
5015568 | May 1991 | Tsujimoto et al. |
5149628 | September 1992 | Croce |
5198338 | March 1993 | Croce |
5202429 | April 1993 | Tsujimoto et al. |
5459251 | October 1995 | Tsujimoto et al. |
5506106 | April 1996 | Croce et al. |
5506344 | April 1996 | Tsujimoto et al. |
5523393 | June 1996 | Tsujimoto et al. |
5567586 | October 1996 | Croce |
5595869 | January 1997 | Tsujimoto et al. |
5633135 | May 1997 | Croce et al. |
5633136 | May 1997 | Croce et al. |
5674682 | October 1997 | Croce et al. |
5688649 | November 1997 | Croce et al. |
5695944 | December 1997 | Croce et al. |
5928884 | July 1999 | Croce et al. |
5939258 | August 1999 | Croce et al. |
5985598 | November 1999 | Russo et al. |
6040140 | March 2000 | Croce et al. |
6130201 | October 2000 | Croce et al. |
6187536 | February 2001 | Weinberg et al. |
6242212 | June 2001 | Croce et al. |
6255293 | July 2001 | Kimchi |
6258541 | July 2001 | Chapkin et al. |
6774217 | August 2004 | Croce et al. |
6924414 | August 2005 | Croce et al. |
7060811 | June 2006 | Aldaz et al. |
7141417 | November 2006 | Croce et al. |
7175995 | February 2007 | Russo et al. |
7217568 | May 2007 | Jamieson et al. |
7220834 | May 2007 | Croce et al. |
7232806 | June 2007 | Tuschl et al. |
7390792 | June 2008 | Srivastava et al. |
7585969 | September 2009 | Stoffel et al. |
7592441 | September 2009 | Bentwich et al. |
7618814 | November 2009 | Bentwich et al. |
7642348 | January 2010 | Bentwich et al. |
7667090 | February 2010 | Croce |
7670840 | March 2010 | Croce et al. |
7709616 | May 2010 | Bentwich et al. |
7723030 | May 2010 | Croce et al. |
7723035 | May 2010 | Croce et al. |
7728189 | June 2010 | Croce |
7749715 | July 2010 | Russo et al. |
7777005 | August 2010 | Croce et al. |
7888010 | February 2011 | Brown et al. |
7919245 | April 2011 | Brown et al. |
2001/0026796 | October 2001 | Croce et al. |
2002/0086331 | July 2002 | Croce et al. |
2002/0116726 | August 2002 | Croce et al. |
2002/0132290 | September 2002 | Frazer |
2004/0033502 | February 2004 | Williams et al. |
2004/0078834 | April 2004 | Croce |
2004/0152112 | August 2004 | Croce et al. |
2004/0265316 | December 2004 | Croce et al. |
2004/0265930 | December 2004 | Sun et al. |
2005/0019890 | January 2005 | Croce |
2005/0059005 | March 2005 | Tuschl et al. |
2005/0069918 | March 2005 | Claret |
2005/0074797 | April 2005 | Croce et al. |
2005/0075492 | April 2005 | Chen et al. |
2005/0112630 | May 2005 | Shaughnessy et al. |
2005/0164252 | July 2005 | Yeung |
2005/0176025 | August 2005 | McSwiggen et al. |
2005/0181385 | August 2005 | Linsley et al. |
2005/0186589 | August 2005 | Kowalik et al. |
2005/0256072 | November 2005 | Aronin et al. |
2005/0260639 | November 2005 | Nakamura et al. |
2005/0266443 | December 2005 | Croce et al. |
2005/0287530 | December 2005 | Croce et al. |
2006/0019286 | January 2006 | Horvitz et al. |
2006/0024780 | February 2006 | Aldaz et al. |
2006/0037088 | February 2006 | Li |
2006/0075511 | April 2006 | Croce et al. |
2006/0084059 | April 2006 | Yip et al. |
2006/0099619 | May 2006 | Remacle et al. |
2006/0105340 | May 2006 | Croce et al. |
2006/0105360 | May 2006 | Croce et al. |
2006/0127895 | June 2006 | Sabapathy |
2006/0165659 | July 2006 | Croce et al. |
2006/0166918 | July 2006 | Heidenreich et al. |
2006/0185027 | August 2006 | Bartel et al. |
2006/0188924 | August 2006 | Russo et al. |
2006/0188959 | August 2006 | Croce et al. |
2006/0189557 | August 2006 | Slack et al. |
2006/0247448 | November 2006 | Boivin et al. |
2006/0292616 | December 2006 | Neely et al. |
2007/0036765 | February 2007 | Civin et al. |
2007/0050146 | March 2007 | Bentwich et al. |
2007/0054849 | March 2007 | Nakamura et al. |
2007/0065840 | March 2007 | Naguibneva et al. |
2007/0065844 | March 2007 | Golub et al. |
2007/0072230 | March 2007 | Croce et al. |
2007/0092882 | April 2007 | Wang et al. |
2007/0099196 | May 2007 | Kauppinen et al. |
2007/0123482 | May 2007 | Stoffel et al. |
2007/0161004 | July 2007 | Brown et al. |
2007/0178105 | August 2007 | Croce et al. |
2007/0178502 | August 2007 | Reed |
2007/0212727 | September 2007 | Szalay et al. |
2007/0213292 | September 2007 | Stoffel et al. |
2007/0259352 | November 2007 | Bentwich et al. |
2007/0292878 | December 2007 | Raymond |
2008/0026951 | January 2008 | Brown et al. |
2008/0050744 | February 2008 | Brown et al. |
2008/0171667 | July 2008 | Brown et al. |
2008/0176766 | July 2008 | Brown et al. |
2008/0182245 | July 2008 | Brown et al. |
2008/0193943 | August 2008 | Murray |
2008/0254473 | October 2008 | Chen et al. |
2008/0256650 | October 2008 | Croce |
2008/0261908 | October 2008 | Croce et al. |
2008/0300211 | December 2008 | Baltimore et al. |
2008/0306006 | December 2008 | Croce et al. |
2008/0306017 | December 2008 | Croce et al. |
2008/0306018 | December 2008 | Croce et al. |
2009/0005336 | January 2009 | Wang |
2009/0023594 | January 2009 | Mouritzen et al. |
2009/0029932 | January 2009 | Voinnet et al. |
2009/0061424 | March 2009 | Chen |
2009/0092974 | April 2009 | Davison et al. |
2009/0099034 | April 2009 | Ahlquist et al. |
2009/0123533 | May 2009 | Croce et al. |
2009/0123912 | May 2009 | Raymond |
2009/0123933 | May 2009 | Mishra |
2009/0131348 | May 2009 | Labourier et al. |
2009/0131354 | May 2009 | Bader et al. |
2009/0131356 | May 2009 | Bader et al. |
2009/0163430 | June 2009 | Johnson et al. |
2009/0163434 | June 2009 | Bader et al. |
2009/0163435 | June 2009 | Bader et al. |
2009/0175827 | July 2009 | Byrom et al. |
2009/0176723 | July 2009 | Brown et al. |
2009/0192102 | July 2009 | Bader et al. |
2009/0192111 | July 2009 | Bader et al. |
2009/0192114 | July 2009 | Ovcharenko et al. |
2009/0209450 | August 2009 | Croce et al. |
2009/0222934 | September 2009 | Croce |
2009/0227533 | September 2009 | Bader et al. |
2009/0232893 | September 2009 | Bader et al. |
2009/0233297 | September 2009 | Mambo et al. |
2009/0253780 | October 2009 | Takeshita et al. |
2009/0263803 | October 2009 | Beaudenon et al. |
2009/0270484 | October 2009 | Croce et al. |
2009/0281167 | November 2009 | Shen et al. |
2009/0306194 | December 2009 | Ford et al. |
2010/0004322 | January 2010 | Croce |
2010/0048681 | February 2010 | Croce |
2010/0099200 | April 2010 | Nazabal et al. |
2010/0104662 | April 2010 | Oren et al. |
2010/0120898 | May 2010 | Croce et al. |
2010/0137410 | June 2010 | Croce |
2010/0144850 | June 2010 | Croce |
2010/0173319 | July 2010 | Croce et al. |
2010/0184032 | July 2010 | Georgantas et al. |
2010/0184830 | July 2010 | Croce et al. |
2010/0184842 | July 2010 | Croce |
2010/0192235 | July 2010 | Croce |
2010/0196426 | August 2010 | Skog et al. |
2010/0197770 | August 2010 | Wang et al. |
2010/0197774 | August 2010 | Croce et al. |
2010/0203544 | August 2010 | Croce et al. |
2010/0234241 | September 2010 | Croce et al. |
2010/0249213 | September 2010 | Croce |
2010/0257618 | October 2010 | Croce et al. |
2010/0317610 | December 2010 | Croce |
2533701 | Feb 2005 | CA | |||
2587189 | Dec 2006 | CA | |||
2877350 | May 2006 | FR | |||
9015156 | Dec 1990 | WO | |||
9100364 | Jan 1991 | WO | |||
9107424 | May 1991 | WO | |||
9312136 | Jun 1993 | WO | |||
9410343 | May 1994 | WO | |||
9424308 | Oct 1994 | WO | |||
9426930 | Nov 1994 | WO | |||
9613514 | May 1996 | WO | |||
9635124 | Nov 1996 | WO | |||
9729119 | Aug 1997 | WO | |||
9809510 | Mar 1998 | WO | |||
0003685 | Jan 2000 | WO | |||
0050565 | Aug 2000 | WO | |||
0055169 | Sep 2000 | WO | |||
0076524 | Dec 2000 | WO | |||
0144466 | Jun 2001 | WO | |||
0168666 | Sep 2001 | WO | |||
0177343 | Oct 2001 | WO | |||
0187958 | Nov 2001 | WO | |||
02064171 | Aug 2002 | WO | |||
02064172 | Aug 2002 | WO | |||
03029459 | Apr 2003 | WO | |||
03078662 | Sep 2003 | WO | |||
03092370 | Nov 2003 | WO | |||
2004033659 | Apr 2004 | WO | |||
2004043387 | May 2004 | WO | |||
2004079013 | Sep 2004 | WO | |||
2004098377 | Nov 2004 | WO | |||
2005013901 | Feb 2005 | WO | |||
2005017711 | Feb 2005 | WO | |||
2005020795 | Mar 2005 | WO | |||
2005060661 | Jul 2005 | WO | |||
2005078139 | Aug 2005 | WO | |||
2005079397 | Sep 2005 | WO | |||
2005080601 | Sep 2005 | WO | |||
2005103298 | Nov 2005 | WO | |||
2005118806 | Dec 2005 | WO | |||
2006105486 | Oct 2006 | WO | |||
2006108718 | Oct 2006 | WO | |||
2006119266 | Nov 2006 | WO | |||
2006133022 | Dec 2006 | WO | |||
2006137941 | Dec 2006 | WO | |||
2007016548 | Feb 2007 | WO | |||
2007033023 | Mar 2007 | WO | |||
2007044413 | Apr 2007 | WO | |||
2007081680 | Jul 2007 | WO | |||
2007081720 | Jul 2007 | WO | |||
2007081740 | Jul 2007 | WO | |||
2007084486 | Jul 2007 | WO | |||
2007109236 | Sep 2007 | WO | |||
2007112097 | Oct 2007 | WO | |||
2007112754 | Oct 2007 | WO | |||
2007/127190 | Nov 2007 | WO | |||
2008008430 | Jan 2008 | WO | |||
2008/036168 | Mar 2008 | WO | |||
2008036776 | Mar 2008 | WO | |||
2008054828 | May 2008 | WO | |||
2008070082 | Jun 2008 | WO | |||
2008073915 | Jun 2008 | WO | |||
2008073920 | Jun 2008 | WO | |||
2008094545 | Aug 2008 | WO | |||
2008097277 | Aug 2008 | WO | |||
2008136971 | Nov 2008 | WO | |||
2008153987 | Dec 2008 | WO | |||
2008157319 | Dec 2008 | WO | |||
2009018303 | Feb 2009 | WO | |||
2009020905 | Feb 2009 | WO | |||
2009026487 | Feb 2009 | WO | |||
2009033140 | Mar 2009 | WO | |||
2009049129 | Apr 2009 | WO | |||
2009055773 | Apr 2009 | WO | |||
2009064590 | May 2009 | WO | |||
2009070653 | Jun 2009 | WO | |||
2009100029 | Aug 2009 | WO | |||
2009108853 | Sep 2009 | WO | |||
2009108856 | Sep 2009 | WO | |||
2009108860 | Sep 2009 | WO | |||
2009108866 | Sep 2009 | WO | |||
2009152300 | Dec 2009 | WO | |||
2010019694 | Feb 2010 | WO | |||
2010059779 | May 2010 | WO | |||
2010065156 | Jun 2010 | WO | |||
2010099161 | Sep 2010 | WO | |||
Lu et al, A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference, 2009, Nucl.Acids Res., vol. 37, No. 3, e24:1-10. cited by examiner . Murrow et al, Identification of WEE1 as a potential molecular target in cancer cells by RNAi screening of the human tyrosine kinome, published online Oct. 2009, Breast Cancer Res Treat, 122: 347-357. cited by examiner . Kendall et al, Analysis of Genetic Alterations and Clonal Proliferation in Children Treated for Acute Lymphocytic Leukemia, 2006, Cancer Res, 66: 8455-8461. cited by examiner . EP Search Report, Application No. 12165636.7 dated Jun. 8, 2012. cited by applicant . EP Search Report, Application No. 12165638.3 dated Jun. 12, 2012. cited by applicant . Australian Government, Examiner's First Report, Appln. No. 2007243475, Dated Mar. 30, 2012. cited by applicant . Australian Office Action, Application No. 2006291165 dated Feb. 13, 2012. cited by applicant . Australian Office Action, Application No. 2006291165 dated Aug. 23, 2011. cited by applicant . Australian Office Action, Application No. 2007227423 dated Apr. 13, 2012. cited by applicant . Australian Office Action, Application No. 2007205257 dated Dec. 22, 2011. cited by applicant . Australian Office Action, Application No. 2007205234 dated Sep. 20, 2011. cited by applicant . Canadian Intellectual Property Office, Requisition by the Examiner, Application No. 2,635,616, Dated Feb. 21, 2011. cited by applicant . Canadian Office Action, Application No. 2,635,616, dated Feb. 27, 2011. cited by applicant . Canadian Office Action, Application No. 2,621,441, dated Feb. 1, 2011. cited by applicant . Canadian Office Action, Application No. 2,617,581, dated Apr. 2, 2012. cited by applicant . Canadian Office Action, Application No. 2,617,581, dated Feb. 1, 2011. cited by applicant . Chinese Office Action, Application No. 200680036598.3 dated Feb. 24, 2011. cited by applicant . Chinese Office Action, Application No. 200880112585.9 dated May 24, 2012. cited by applicant . Chinese Office Action, Application No. 200780040146.7 dated May 25, 2011. cited by applicant . Chinese Office Action, Application No. 20088011920639 dated May 3, 2012. cited by applicant . Chinese Office Action, Application No. 200780005821.2 dated Jan. 26, 2011. cited by applicant . Chinese Office Action, Application No. 200780033066.9 dated Jun. 26, 2012. cited by applicant . Chinese Office Action, Application No. 200680039776.8 dated Jun. 30, 2011. cited by applicant . Communication Concerning Office Action Received from Japanese Patent Office dated Jan. 30, 2012, Japanese Patent Application No. 2008-531200. cited by applicant . EP Search Report, Application No. 12154298.9 dated Jun. 4, 2012. cited by applicant . EP Search Report, Application No. 11196253.6 dated Apr. 24, 2012. cited by applicant . EP Search Report, Application No. 11196261.9 dated Feb. 28, 2012. cited by applicant . EP Search Report, Application No. 11196264-3 dated Feb. 28, 2012. cited by applicant . EP Search Report, Application No. 11196250.2 dated Apr. 24, 2012. cited by applicant . EP Search Report, Application No. 11196262.7 dated Feb. 28, 2012. cited by applicant . EP Search Report, Application No. 11196256.9 dated Feb. 28, 2012. cited by applicant . EP Search Report, Application No. 11196254.4 dated Feb. 28, 2012. cited by applicant . EP Search Report, Application No. 11196190.0 dated Apr. 24, 2012. cited by applicant . EP Search Report, Application No. 11196265.0 dated Mar. 5, 2012. cited by applicant . EP Search Report, Application No. 08782609.5 dated Oct. 28, 2010. cited by applicant . European Communication Pursuant to Article 94(3) EPC, Application No. 07717903.4, dated Apr. 25, 2012. cited by applicant . European Communication Pursuant to Article 94(3) EPC, Application No. 07810382.7, dated Dec. 8, 2010. cited by applicant . European Communication Pursuant to Article 94(3) EPC, Application No. 08767439.9, dated Mar. 15, 2011. cited by applicant . European Communication Pursuant to Article 94(3) EPC, Application No. 07716208.9, dated Sep. 13, 2011. cited by applicant . European Communication Pursuant to Article 94(3) EPC, Application No. 08799295.4, dated Nov. 18, 2011. cited by applicant . European Communication Pursuant to Article 94(3) EPC, Application No. 07867402.5, dated Jan. 5, 2011. cited by applicant . European Communication Pursuant to Article 94(3) EPC, Application No. 08768266.2, dated Apr. 18, 2011. cited by applicant . European Communication Pursuant to Article 94(3) EPC, Application No. 08767439.6, dated Feb. 12, 2011. cited by applicant . European Communication Pursuant to Article 94(3) EPC, Application No. 08841700.1, dated Jun. 1, 2012. cited by applicant . European Communication Pursuant to Article 94(3) EPC, Application No. 07867402.5, dated Apr. 10, 2012. cited by applicant . European Communication Pursuant to Article 94(3) EPC, Application No. 06800599.0 dated Nov. 25, 2011. cited by applicant . European Communication Pursuant to Article 94(3)EPC, Application No. 06814375.9 dated Oct. 14, 2011. cited by applicant . European Patent Application, EP 1795203 A2, Croce et al., Application No. 06010581.4, filed Feb. 7, 1997, published Jun. 13, 2007. cited by applicant . European Seach Report, Application No. 11151749.6, dated Feb. 8, 2011. cited by applicant . European Seach Report, Application No. 09714868.8 dated Aug. 1, 2011. cited by applicant . European Search Reoprt, Application No. 08841700.1, dated Jan. 4, 2011. cited by applicant . European Search Report, Application No. 08796821.0 dated Aug. 4, 2010. cited by applicant . European Search Report, Application No. 08770974.4, dated Oct. 21, 2011. cited by applicant . European Search Report, Application No. 06814375.9 dated Oct. 8, 2009. cited by applicant . European Search Report, Application No. 08767439.6 dated May 12, 2010. cited by applicant . European Search Report, Application No. 06800599.0 dated Oct. 19, 2009. cited by applicant . European Search Report, Application No. 07872618.9 dated Jul. 5, 2010. cited by applicant . European Search Report, Application No. 06825457.2 dated Sep. 16, 2009. cited by applicant . European Search Report, Application No. 08768266.2 dated Jul. 1, 2010. cited by applicant . European Search Report, Application No. 08713330.2, dated Jul. 22, 2011. cited by applicant . European Search Report, Application No. 07717903.4 dated Oct. 23, 2009. cited by applicant . European Search Report, Application No. 08841700.1 dated Jun. 2, 2010. cited by applicant . European Search Report, Application No. 07810382.7 dated Sep. 14, 2009. cited by applicant . European Search Report, Application No. 11151772-8, dated Feb. 8, 2011. cited by applicant . European Search Report, Application No. 11151769-4, dated Feb. 8, 2011. cited by applicant . European Search Report, Application No. 07867402.5 dated Mar. 16, 2010. cited by applicant . European Search Report, Application No. 09713926.5 dated Jul. 21, 2011. cited by applicant . European Search Report, Application No. 07717734.3 dated Nov. 9, 2009. cited by applicant . European Search Report, Application No. 11151771-0, dated Feb. 8, 2011. cited by applicant . European Search Report, Application No. 08798444.9-2402, PCT/US2008/073964, dated Dec. 16, 2010. cited by applicant . European Search Report, Application No. 07716208.9 dated Nov. 10, 2009. cited by applicant . European Search Report, Application No. 08799295.4-2402, PCT/US2008/075565, dated Nov. 9, 2010. cited by applicant . European Search Report, Application No. 07753450.1 dated Jan. 12, 2009. cited by applicant . European Supplementary Search Report, Application No. 09715064.3 dated May 24, 2011. cited by applicant . Japanese Office Action dated Feb. 24, 2012, Japanese Patent Application No. 2008-549532. cited by applicant . Japanese Office Action dated Feb. 22, 2012, Japanese Patent Application No. 2008-549549. cited by applicant . Japanese Office Action dated Jan. 4, 2012, Japanese Patent Application No. 2008-5251070. cited by applicant . Japanese Office Action dated Feb. 24, 2012, Japanese Patent Application No. 2008-549555. cited by applicant . Notice of Allowance and Fees Due in U.S. Appl. No. 12/298,221, filed Nov. 10, 2008, mailing date Nov. 30, 2009. cited by applicant . Notice of Allowance and Fees Due in U.S. Appl. No. 12/160,064, filed Jul. 3, 2008, mailing date Nov. 20, 2009. cited by applicant . Office Action issued in U.S. Appl. No. 12/160,064, filed Jul. 3, 2008, mailing date Aug. 10, 2009. cited by applicant . Office Action issued in U.S. Appl. No. 12/373,358, filed Feb. 11, 2009, mailing date Aug. 20, 2010. cited by applicant . Office Action issued in U.S. Appl. No. 12/160,061, filed Jul. 3, 2008, mailing date Apr. 24, 2009. cited by applicant . Office Action issued in U.S. Appl. No. 12/160,034, filed Jul. 3, 2008, mailing date Jun. 7, 2010. cited by applicant . Office Action issued in U.S. Appl. No. 12/293,471, filed Oct. 9, 2008, mailing date Jun. 8, 2010. cited by applicant . Office Action issued in U.S. Appl. No. 12/160,061, filed Jul. 3, 2008, mailing date Mar. 12, 2010. cited by applicant . Office Action issued in U.S. Appl. No. 12/160,061, filed Jul. 3, 2008, mailing date Oct. 30, 2009. cited by applicant . Office Action issued in U.S. Appl. No. 12/442,018, filed Mar. 27, 2009, mailing date Apr. 15, 2010. cited by applicant . Office Action issued in U.S. Appl. No. 12/083,067, filed Jun. 20, 2008, mailing date Jul. 8, 2010. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2009/035470 filed Feb. 27, 2009, dated Aug. 31, 2010. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2007/000159 filed Jan. 3, 2007, dated Jul. 8, 2008. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2006/035100 filed Sep. 11, 2006, dated Mar. 18, 2008. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2007/000103 filed Jan. 3, 2007, dated Jul. 8, 2008. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2010/025173 filed Feb. 24, 2010, dated Sep. 9, 2011. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2010/057758 filed Nov. 23, 2010, dated Jun. 7, 2012. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2009/065072 filed Nov. 19, 2009, dated Jun. 3, 2011. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2008/073964 filed Aug. 22, 2008, dated Feb. 24, 2010. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2008/075565 filed Sep. 8, 2008, dated Mar. 9, 2010. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2008/071532 filed Jul. 30, 2008, dated Feb. 2, 2010. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2008/066870 filed Jun. 13, 2008, dated Dec. 17, 2009. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2008/001157 filed Jan. 29, 2008, dated Aug. 4, 2009. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US/2008/072081 filed Aug. 4, 2008, dated Feb. 9, 2010. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2009/035458 filed Feb. 27, 2009, dated Aug. 31, 2010. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US/2007/023660 filed Nov. 1, 2007, dated May 5, 2009. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2008/005503 filed Apr. 29, 2008, dated Nov. 3, 2009. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2007/006824 filed Mar. 19, 2007, dated Sep. 23, 2008. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2007/020215 filed Sep. 17, 2007, dated Mar. 24, 2009. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2008/081294 filed Oct. 27, 2008, dated Apr. 27, 2010. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2009/038214 filed Mar. 25, 2009, dated Jun. 16, 2011. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2007/015892 filed Jul. 12, 2007, dated Jan. 13, 2009. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2006/038824 filed Oct. 4, 2006, dated Apr. 9, 2008. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2008/007196 filed Jun. 9, 2008, dated Dec. 11, 2009. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2007/000024 filed Jan. 3, 2007, dated Jul. 8, 2008. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2009/035482 filed Feb. 27, 2009, dated Aug. 31, 2010. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2007/009910 filed Apr. 24, 2007, dated Oct. 28, 2008. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2009/035463 filed Feb. 27, 2009, dated Aug. 31, 2010. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2006/029889 filed Jul. 31, 2006, dated Feb. 5, 2008. cited by applicant . PCT International Preliminary Report on Patentability, PCT/US2008/079482 filed Oct. 10, 2008, dated Apr. 13, 2010. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2008/71532 filed Jul. 30, 2008, dated Apr. 17, 2009. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2008/84821 filed Nov. 26, 2008, dated Feb. 17, 2009. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2007/00024 filed Jan. 3, 2007, dated Nov. 5, 2007. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2007/006824 filed Mar. 19, 2007, dated Mar. 3, 2008. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2007/09910 filed Apr. 24, 2007, dated Feb. 13, 2008. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2008/72081 filed Aug. 4, 2008, dated Jan. 14, 2009. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2007/15892 filed Jul. 12, 2007, dated Sep. 30, 2008. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2008/66870 filed Jun. 13, 2008, dated Nov. 10, 2008. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2009/38214 filed Mar. 25, 2009, dated Aug. 14, 2009. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2007/20215 filed Sep. 17, 2007, dated Jul. 25, 2008. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2008/07196 filed Jun. 9, 2008, dated Nov. 19, 2008. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2008/01157 filed Jan. 29, 2008, dated Aug. 7, 2008. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2006/38824 filed Oct. 4, 2006, dated Aug. 9, 2007. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2008/05503 filed Apr. 29, 2008, dated Sep. 25, 2008. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2008/73964 filed Aug. 22, 2008, dated Dec. 24, 2008. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2007/23660 filed Nov. 1, 2007, dated Sep. 16, 2008. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2009/35463 filed Feb. 27, 2009, dated Aug. 13, 2009. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2008/81294 filed Oct. 27, 2008, dated Mar. 26, 2009. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2009/35482 filed Feb. 27, 2009, dated Jul. 17, 2009. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2009/53586 filed Aug. 12, 2009, dated Oct. 28, 2009. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2008/79482 filed Oct. 10, 2008, dated Dec. 22, 2008. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2008/75565 filed Sep. 8, 2008, dated Dec. 9, 2008. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2009/35458 filed Feb. 27, 2009, dated Jul. 28, 2009. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2007/00159 filed Jan. 3, 2007, dated Apr. 11, 2008. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2010/025173 filed Feb. 24, 2010, dated Jul. 6, 2010. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2012/020911 filed Jan. 11, 2012, dated Apr. 25, 2012. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2009/65072 filed Nov. 19, 2009, dated Mar. 3, 2010. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2007/006824 filed Mar. 19, 2007, dated May 14, 2008. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2009/35470 filed Feb. 27, 2009, dated Jun. 16, 2009. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2006/35100 filed Sep. 11, 2006, dated Sep. 5, 2007. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2006/29889 filed Jul. 31, 2006, dated Jul. 10, 2007. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2007/00103 filed Jan. 3, 2007, dated Dec. 3, 2007. cited by applicant . PCT International Search Report and the Written Opinion, PCT/US2009/46999 filed Jun. 11, 2009, dated Nov. 23, 2009. cited by applicant . PCT Invitation to Pay Additional Fees, PCT/US2012/028016 filed Mar. 7, 2012, dated May 29, 2012. cited by applicant . Aiba, M. "Pathology of the Breast Carcinoma from the Viewpoint of the Proliferative Activity and Grade of Malignancy," JP J Cancer Clin, 2000, pp. 475-181, vol. 46, No. 5. cited by applicant . Akahoshi, M. et al., "Myeloproliferative Disorders Terminating in Acute Megakaryoblastic Leukemia with Chromosome 3q26 Abnormality," Cancer, 1987, pp. 2654-2661, vol. 60. cited by applicant . Akao, Y. et al., "let-7 MicroRNA Functions as a Potential Growth Suppressor in Human Colon Cancer Cells," Biol. Pharm. Bull., May 2006, pp. 903-906, vol. 29, No. 5. cited by applicant . Alvarez-Secord, A. et al., "Maspin Expression in Epithelial Ovarian Cancer and Associations with Poor Prognosis: A Gynecologic Oncology Group Study," Gynecologic Oncology, 2006, pp. 390-397, vol. 101. cited by applicant . Ambros, V. et al., "A Uniform System for MicroRNA Annotation," RNA, 2003, pp. 277-279, vol. 9. cited by applicant . Ambs, S. et al., "Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer," Cancer Research, Aug. 2008, pp. 6162-6170, vol. 68, No. 15. cited by applicant . Aqeilan, R. I. et al., "Targeted Deletion of WWOX Reveals a Tumor Suppressor Function," PNAS, Mar. 2007, pp. 3949-3954, vol. 104, No. 10. cited by applicant . Baira, E. et al., "Ultraconserved Elements: Genomics, Function and Disease," RNA Biology, Jul. 2008, pp. 132-134, vol. 5, No. 3. cited by applicant . Bandres, E. et al., "Identification by Real-Time PCR of 13 Mature MicroRNAs Differentially Expressed in Colorectal Cancer and Non-Tumoral Tissues," Molecular Cancer, Jul. 2006, 10 pages, vol. 5, No. 29. cited by applicant . Bartel, D. P., "MicroRNAs: Target Recognition and Regulatory Functions," Cell, Jan. 2009, pp. 215-233, vol. 136. cited by applicant . Bednarek, A. K. et al., "WWOX, the FRA16D Gene, Behaves as a Suppressor of Tumor Growth," Cancer Research, Nov. 2001, pp. 8068-8073, vol. 61. cited by applicant . Bejenaro, et al., "Ultraconserved Elements in the Human Genome," Electronic Suppl. Data, Science, 2004. cited by applicant . Bejerano, G. et al., "Ultraconserved Elements in the Human Genome," Science, May 2004, pp. 1321-1325, vol. 304. cited by applicant . Bell, D. A., "Origins and Molecular Pathology of Ovarian Cancer," Modern Pathology, 2005, pp. S19-S32, vol. 18. cited by applicant . Bichi, R. et al., "Human Chronic Lymphocytic Leukemia Modeled in Mouse by Targeted TCL1 Expression," PNAS, May 2002, pp. 6955-6960, vol. 99, No. 10. cited by applicant . Bloomston, M. et al., "MicroRNA Expression Patterns to Differentiate Pancreatic Adenocarcinoma from Normal Pancreas and Chronic Pancreatitis," JAMA, May 2007, pp. 1901-1908 vol. 297, No. 1. cited by applicant . Blum, W. et al., "Clinical Response and miR-29b Predictive Significance in Older AML Patients Treated With a 10-Day Schedule of Decitabine," PNAS, Apr. 2010, pp. 7473-7478, vol. 107, No. 16. cited by applicant . Boland, C.R. et al., "Lynch Syndrome: Form, Function, Proteins, and Basketball," Gastroenterology, Aug. 2005, pp. 751-755, vol. 129, No. 2. cited by applicant . Braun et al., "p53-Responsive MicroRNAs 192 and 215 are Capable of Inducing Cell Cycle Arrest," Cancer Research, 2008, pp. 10094-10104, vol. 68. cited by applicant . Brueckner, B. et al., "The Human let-7a-3 Locus Contains an Epigenetically Regulated MicroRNA Gene with Oncogenic Function," Cancer Research, Feb. 2007, pp. 1419-1423, vol. 67, No. 4. cited by applicant . Budhu, A. et al., "A Unique Metastasis-Related MicroRNA Expression Signature is a Prognostic Indicator of Survival and Recurrence in Hepatocellular Carcinoma," Hepatology, 2007, p. 791A, vol. 46, No. 4, Suppl. 1, Abstract #1249. cited by applicant . Budhu, A. et al., "Identification of Metastasis-Related MicroRNAs in Hepatocellular Carcinoma," Hepatology, Mar. 2008, pp. 897-907, vol. 47, No. 3. cited by applicant . Caldas, C. et al., "Sizing Up miRNAs as Cancer Genes," Nature Medicine, Jul. 2005, pp. 712-714, vol. 11, No. 7. cited by applicant . Calin, G. A. et al., "Human MicroRNA Genes are Frequently Located at Fragile Sites and Genomic Regions Involved in Cancers," PNAS, Mar. 2004, pp. 2999-3004, vol. 101, No. 9. cited by applicant . Calin, G. A. et al., "MiR-15a and MiR-16-1 Cluster Functions in Human Leukemia," PNAS, Apr. 2008, pp. 5166-5171, vol. 105, No. 13. cited by applicant . Calin, G. A. et al., "MicroRNA Profiling Reveals Distinct Signatures in B Cell Chronic Lymphocytic Leukemias," PNAS, Aug. 2004, pp. 11755-11760, vol. 101, No. 32. cited by applicant . Calin, G. A. et al., "A MicroRNA Signature Associated with Prognosis and Progression in Chronic Lymphocytic Leukemia," The New England Journal of Medicine, Oct. 2005, pp. 1793-1801, vol. 353, No. 17. cited by applicant . Calin, G. A. et al., "Frequent Deletions and Down-Regulation of MicroRNA Genes miR15 and miR16 at 13q14 in Chronic Lymphocytic Leukemia," PNAS, Nov. 2002, pp. 15524-15529, vol. 99, No. 24. cited by applicant . Calin, G. A. et al., "Ultraconserved Regions Encoding ncRNAs are Altered in Human Leukemias and Carcinomas," Cancer Cell, Sep. 2007, pp. 215-229, vol. 12. cited by applicant . Calin, G. A. et al., "Chromosomal Rearrangements and MicroRNAs: A New Cancer Link with Clinical Implications," The Journal of Clinical Investigation, Aug. 2007, pp. 2059-2066, vol. 117, No. 8. cited by applicant . Calin, G. A. et al., "MicroRNA Signatures in Human Cancers," Nature Reviews Cancer, Nov. 2006, pp. 857-866, vol. 6. cited by applicant . Cannistra, S.A., "Cancer of the Ovary," The New England Journal of Medicine, 2004, pp. 2519-2529, vol. 351, No. 25. cited by applicant . Castoldi, M. et al., "A Sensitive Array for MicroRNA Expression Profiling (miChip) Based on Locked Nucleic Acids (LNA)," RNA, 2006, pp. 913-920, vol. 12. cited by applicant . Chan, J. A. et al., "MicroRNA-21 is an Antiapoptotic Factor in Human Glioblastoma Cells," Cancer Research, Jul. 2005, pp. 6029-6033, vol. 65, No. 14. cited by applicant . Chang, N.-S. et al., "Molecular Mechanisms Underlying WOX1 Activation During Apoptotic and Stress Responses," Biochemical Pharmacology, 2003, pp. 1347-1354, vol. 66. cited by applicant . Chang, T.-C. et al., "Widespread MicroRNA Repression by Myc Contributes to Tumorigenesis," Nat Genet., Jan. 2008, pp. 43-50, vol. 40, No. 1. cited by applicant . Chen, C.-Z. et al., "MicroRNAs as Regulators of Mammalian Hematopoiesis," Seminars in Immunology, 2005, pp. 155-165, vol. 17. cited by applicant . Cheng, A. M. et al., "Antisense Inhibition of Human miRNAs and Indications for an Involvement of miRNA in Cell Growth and Apoptosis," Nucleic Acids Research, 2005, pp. 1290-1297, vol. 33, No. 4. cited by applicant . Chim, S.S.C. et al., "Detection and Characterization of Placental MicroRNAs in Maternal Plasma," Clinical Chemistry, 2008, pp. 482-490, vol. 54, No. 3. cited by applicant . Ciafre, S. A. et al., "Extensive Modulation of a Set of MicroRNAs in Primary Glioblastoma," Biochemical and Biophysical Research Communications, 2005, pp. 1351-1358, vol. 334. cited by applicant . Cimmino, A. et al., Corrections to "miR-15 and miR-16 Induce Apoptosis by Targeting BCL2," PNAS, Feb. 2006, pp. 2464-2465, vol. 103, No. 7. cited by applicant . Cimmino, A. et al., "miR-15 and miR-16 Induce Apoptosis by Targeting BCL2," PNAS, Sep. 2005, pp. 13944-13949, vol. 102, No. 39. cited by applicant . Costinean, S. et al., "Pre-B Cell Proliferation and Lymphoblastic Leukemia/ High-Grade Lymphoma in E.mu.-miR155 Transgenic Mice," PNAS, May 2006, pp. 7024-7029, vol. 103, No. 18. cited by applicant . Croce, C. M. et al., "Role of FHIT in Human Cancer," Journal of Clinical Oncology, May 1999, pp. 1618-1624, vol. 17, No. 5. cited by applicant . Croce, C. M. et al., "miRNAs, Cancer, and Stem Cell Division," Cell, 2005, pp. 6-7, vol. 36. cited by applicant . Croce, C. M., "Causes and Consequences of MicroRNA Dysregulation in Cancer," Nature Reviews Genetics, Oct. 2009, pp. 704-714, vol. 10. cited by applicant . Croce, C. M., "Oncogenes and Cancer," The New England Journal of Medicine, Jan. 2008, pp. 502-511, vol. 358, No. 5. cited by applicant . Cui, S. et al., "MicroRNAs that Underlie Ovarian Cancer Development and Response to Chemotherapy," 98th AACR Annual Meeting, Apr. 14-18, 2007, Los Angeles, CA. cited by applicant . Dalmay, T. et al., "MicroRNAs and the Hallmarks of Cancer," Oncogene, 2006, pp. 6170-6175, vol. 25. cited by applicant . Davies, B.R. et al., "AZD6244 (ARRY-142886), a Potent Inhibitor of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase 1/2 Kinases: Mechanism of Action in vivo, Pharmacokinetic/Pharmacodynamic Relationship, and Potential for Combination in Preclinical Needs," Mol. Cancer Ther., Aug. 2007, vol. 6, No. 8, pp. 2209-2219. cited by applicant . Davies, F. E. et al., "Insights into the Multistep Transformation of MGUS to Myeloma Using Microarray Expression Analysis," Blood, Dec. 2003, pp. 4504-4511, vol. 102, No. 13. cited by applicant . Debernardi, S. et al., "MicroRNA miR-181a Correlates with Morphological Sub-Class of Acute Myeloid Leukemia and the Expression of its Target Genes in Global Genome-Wide Analysis," Leukemia, 2007, pp. 912-916, vol. 21. cited by applicant . Dohner, H. et al., "Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia," The New England Journal of Medicine, Dec. 2000, pp. 1910-1916, vol. 343, No. 26. cited by applicant . Druck, et al., "FHIT," Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2007, pp. 171-178, vol. 2. cited by applicant . Eiriksdottir, G. et al., "Mapping Loss of Heterozygosity at Chromosome 13q: Loss at 13q12-q13 is Associated wit Breast Tumour Progression and Poor Prognosis," European Journal of Cancer, 1998, pp. 2076-2081, vol. 34, No. 13. cited by applicant . Eis, P. S. et al., "Accumulation of miR-155 and BIC RNA in Human B Cell Lymphomas," PNAS, Mar. 2005, pp. 3627-3632, vol. 102, No. 10. cited by applicant . Esquela-Kerscher, A. et al., "Oncomirs--MicroRNAs with a Role in Cancer," Nature Reviews:Cancer, Apr. 2006, pp. 259-269, vol. 6. cited by applicant . Fabbri, M. et al., "MicroRNAs," The Cancer Journal, Jan./Feb. 2008, pp. 1-6, vol. 14, No. 1. cited by applicant . Fabbri, M. et al., "MicroRNA-29 Family Reverts Aberrant Methylation in Lung Cancer by Targeting DNA Methyltransferases 3A and 3B," PNAs, Oct. 2007, pp. 15805-15810, vol. 104, No. 40. cited by applicant . Fabbri, M. et al., "WWOX Gene Restoration Prevents Lung Cancer Growth In Vitro and In Vivo," PNAS, Oct. 2005, pp. 15611-15616, vol. 102, No. 43. cited by applicant . Felli, N. et al., "MicroRNAs 221 and 222 Inhibit Normal Erythropoiesis and Erythroleukemic Cell Growth via Kit Receptor Down-Modulation," PNAS, Dec. 2005, pp. 18081-18086, vol. 102, No. 50. cited by applicant . Feng, G. et al., "Elevated Serum-Circulating RNA in Patients with Conventional Renal Cell Cancer," Anticancer Research, 2008, pp. 321-326, vol. 28. cited by applicant . Flavin, RJ et al., "MicroRNA Gene Expression Profiling in Human Ovarian and Primary Peritoneal Serous Carcinomas" USCAP 96th Annual Meeting, Abstract #897, San Diego, CA, Mar. 2007. cited by applicant . Fong, Y. et al., "Muir-Torre-Like Syndrome in FHIT-Deficient Mice," PNAS, Apr. 2000, pp. 4742-4747, vol. 97, No. 9. cited by applicant . Ford, L.P., "A MicroRNA Expression Signature of Human Solid Tumors Defines Cancer Gene Targets," Leukemia Research, 2006, pp. 511-513, vol. 30. cited by applicant . Fox, T. et al., "A Single Amino Acid Substitution Makes ERK2 Susceptible to Pyridinyl Imidazole Inhibitors of p38 MAP Kinase," Protein Science, 1998, pp. 2249-2255, vol. 7. cited by applicant . Fujuta, S. et al., "miR-21 Gene Expression Triggered by AP-1 is Sustained Through a Double-Negative Feedback Mechanism," J. Mol. Biol., Abstract, 2008, pp. 492-504, vol. 378. cited by applicant . Gailiun, M., "Single MicroRNA Causes Cancer in Transgenic Mice," Research Communications, The Ohio State University, Apr. 2006. cited by applicant . Gang, M. et al., "Expression of Programmed Cell Death 4 and Its Clinicopathological Significance in Human Pancreatic Cancer," Abstract, 2005, pp. 597-600, vol. 27. cited by applicant . Garofalo, M. et al., "MicroRNA Signatures of TRAIL Resistance in Human Non-Small Cell Lung Cancer," Oncogene, 2007, pp. 3854-3855, vol. 27. cited by applicant . Garofalo, M. et al., "miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation," Cancer Cell, Dec. 2009, pp. 498-509, vol. 16. cited by applicant . Garzon, et al., "MicroRNA 29b Functions in Acute Myeloid Leukemia," Prepublished Online, www.bloodjournal.org, Oct. 2009, doi:10.1182/blood-2009-03-211938, pp. 5331-5341, vol. 114. cited by applicant . Garzon, R. et al., "MicroRNA Expression and Function in Cancer," TRENDS in Molecular Medicine, Oct. 2006, pp. 580-587, vol. 12, No. 12. cited by applicant . Garzon, R. et al., "MicroRNA Signatures Associated with Cytogenetics and Outcome in Acute Myeloid Leukemia," ASH Annual Meeting Abstracts, Nov. 2006, Abstract #151, Part 1, p. 498, vol. 108, Issue 11. cited by applicant . Garzon, R. et al., "MicroRNA Signatures Associated with Cytogenetics and Prognosis in Acute Myeloid Leukemia," Blood, Published Online Jan. 2008, DOI: 10.1182/blood-2007-07-098749. cited by applicant . Garzon, R. et al., "MicroRNA Fingerprints During Human Megakaryocytopoiesis," PNAS, Mar. 2006, pp. 5078-5083, vol. 103, No. 13. cited by applicant . Godlewski, J. et al., "Targeting of the Bmi-1 Oncogene/Stem Cell Renewal Factor by MicroRNA-128 Inhibits Glioma Proliferation and Self-Renewal," Cancer Research, Nov. 2008, pp. 9125-9130, vol. 68, No. 22. cited by applicant . Gourley, C. et al., "WWOX Gene Expression Abolishes Ovarian Cancer Tumorigenicity in Vivo and Decreases Attachment to Fibronectin via Integrin .alpha.3," Cancer Research, Jun. 2009, pp. 4835-4842, vol. 69, No. 11. cited by applicant . Griffiths-Jones, S. et al., "miRBase: MicroRNA Sequences, Targets and Gene Nomenclature," Nucleic Acids Research, 2006, pp. D140-D144, vol. 34. cited by applicant . Griffths-Jones, S. et al., "miRBase: Tools for MicroRNA Genomics," Nucleic Acids Research, 2008, pp. D154-D157, vol. 36. cited by applicant . Griffths-Jones, S., "The MicroRNA Registry," Nucleic Acids Research, 2004, pp. D109-D111, vol. 32. cited by applicant . Guimaraes-Sternberg, C. et al., "MicroRNA Modulation of Megakaryoblast Fate Involves Cholinergic Signaling," Leukemia Research, 2006, pp. 583-595, vol. 30. cited by applicant . Guweidhi, A. et al. "Enhanced Expression of 14-3-3sigma in Pancreatic Cancer and its Role in Cell Cycle Regulation and Apoptosis," Carcinogenesis, 2004, pp. 1575-1585, vol. 25, No. 9. cited by applicant . Havelange, V. et al., "MicroRNAs: New Players in Acute Myeloid Leukemia," British Journal of Cancer, 2009, pp. 743-748, vol. 101. cited by applicant . Hayashita, Y. et al., "A Polycistronic MicroRNA Cluster, miR-17-92, is Overexpressed in Human Lung Cancers and Enhances Cell Proliferation," Cancer Research, Nov. 2005, pp. 9628-9632, vol. 65, No. 21. cited by applicant . He, L. et al., "A MicroRNA Polycistron as a Potential Human Oncogene," Nature, Jun. 2005, pp. 828-833, vol. 435. cited by applicant . He, X. et al., "MicroRNA and Esophageal Carcinoma," Journal of Nanjing Medical University, 2007, pp. 201-206, vol. 21, No. 4. cited by applicant . Herling, et al., "TCL1 Shows a Regulated Expression Pattern in Chronic Lymphocytic Leukemia that Correlates with Molecular Subtypes and Proliferative State," Leukemia, Feb. 2006, pp. 280-285, vol. 20, No. 2. cited by applicant . Hiromura, M. et al., "Identification of Nerve Growth Factor-Responsive Element of the TCL1 Promoter as a Novel Negative Regulatory Element," The Journal of Biological Chemistry, Sep. 2006, pp. 27753-27764, vol. 281, No. 38. cited by applicant . Huang, Y.-S. et al., "Microarray Analysis of MicroRNA Expression in Hepatocellular Carcinoma and Non-Tumorous Tissues Without Viral Hepatitis," Journal of Gastroenterology and Hepatology, 2008, pp. 87-94, vol. 23. cited by applicant . Iliopoulos, D. et al., "Inhibition of Breast Cancer Growth InVitro and In Vivo: Effect of Restoration of WWOX Expression," Clin. Cancer Research, Jan. 2007, pp. 268-274, vol. 13, No. 1. cited by applicant . Iliopoulos, D. et al., "Fragile Genes as Biomarkers: Epigenetic Control of WWOX and FHIT in Lung, Breast and Bladder Cancer," Oncogene, 2005, pp. 1625-1633, vol. 24. cited by applicant . Iorio, M. V. et al., "MicroRNA Signatures in Human Ovarian Cancer," Cancer Research, Sep. 2007, pp. 8699-8707, vol. 67, No. 18. cited by applicant . Iorio, M. V. et al., "MicroRNA Gene Expression Deregulation in Human Breast Cancer," Cancer Research, Aug. 2005, pp. 7065-7070, vol. 65, No. 16. cited by applicant . Ishii, H. et al., "Effect of Adenoviral Transduction of the Fragile Histidine Triad Gene into Esophageal Cancer Cells," Cancer Research, Feb. 2001, pp. 1578-1584, vol. 61. cited by applicant . Ivanovska, I. et al., "MicroRNAs in the miR-106b Family Regulate p21/CDKN1A and Promote Cell Cycle Progression," Molecular and Cellular Biology, Apr. 2008, pp. 2167-2174, vol. 28, No. 7. cited by applicant . Jacobs, I.J. et al., "Prevalence Screening for Ovarian Cancer in Postmenopausal Women by CA 125 Measurement and Ultrasonography," BMJ, Apr. 1993, pp. 1030-1034, vol. 306. cited by applicant . Jacobs, I.J. et al., "Progress and Challenges in Screening for Early Detection of Ovarian Cancer," Molecular & Cellular Proteomics, 2004, pp. 355-366, vol. 3. cited by applicant . Jansen, A. P. et al., "Epidermal Expression of the Translation Inhibitor Programmed Cell Death 4 Suppresses Tumorigenesis," Cancer Research, Jul. 2005, pp. 6034-6041, vol. 65, No. 14. cited by applicant . Jazbutyte, V. et al., "MicroNRA-21: From Cancer to Cardiovascular Disease," Current Drug Targets, Abstract, 2010, pp. 926-935, vol. 11. cited by applicant . Jemal, A. et al., "Cancer Statistics, 2008," CA Cancer J. Clin., 2008, pp. 71-96, vol. 58, No. 2. cited by applicant . Ji, J. et al., "MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer," The New England Journal of Medicine, Oct. 2009, pp. 1437-1447, vol. 361, No. 15. cited by applicant . Ji, J. et al., "New Kids on the Block: Diagnostic and Prognostic MicroRNAs in Hepatocellular Carcinoma," Cancer Biology & Therapy, Aug. 2009, pp. 1-8, vol. 8, No. 16. cited by applicant . Ji, L. et al., "Induction of Apoptosis and Inhibition of Tumorigenicity and Tumor Growth by Adenovirus Vector-Mediated Fragile Histidine Triad (FHIT) Gene Overexpression," Cancer Research, Jul. 1999, pp. 3333-3339, vol. 59. cited by applicant . Jiang, J. et al., "Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival," Clin Cancer Research, Jan. 2008, pp. 419-427, vol. 14, No. 2. cited by applicant . Jiang, J. et al., "Real-Time Expression Profiling of MicroRNA Precursors in Human Cancer Cell Lines," Nucleic Acids Research, 2005, pp. 5394-5403, vol. 33, No. 17. cited by applicant . John, B. et al., "Human MicroRNA Targets," PLOS Biology, Nov. 2004, pp. 1862-1879, vol. 2, Issue 11. cited by applicant . Johnson, S. M. et al., "RAS is Regulated by the let-7 MicroRNA Family," Cell, Mar. 2005, pp. 635-647, vol. 120. cited by applicant . Johnson, S. M. et al., "RAS is Regulated by the let-7 MicroRNA Family," Supplemental Data, Cell, Mar. 2005, pp. 635-647, vol. 120. cited by applicant . Kawasaki, H. et al., "MicroRNA-196 Inhibits HOXB8 Expression in Myeloid Differentiation of HL60 Cells," Nucleic Acids Symposium Series, 2004, pp. 211-212, No. 48. cited by applicant . Kelly, L.M. et al., "CT53518, A Novel Selective FLT3 Antagonist for the Treatment of Acute Myelogenous Leukemia (AML)," Cancer Cell, Jun. 2002,pp. 421-432, vol. 1. cited by applicant . Kim, H. et al., "Elevated mRNA Levels of DNA Methyltransferase-1 as an Independent Prognostic Factor in Primary Nonsmall Cell Lung Cancer," Cancer, Sep. 2006, pp. 1042-1049, vol. 107, No. 5. cited by applicant . Kotoula, V. et al., "In Situ Detection of MicroRNAs 146b, 221 and 222 in Human Carcinoma Tissues Reveals Tumor-Type Specific Expression Patterns," In: Proceedings of the 98th Annual Meeting of the American Association for Cancer Research, Apr. 14-18, 2007 Los Angeles, CA: AACR, 2007, 2 pages, Abstract No. 1780. cited by applicant . Koturbash, I. et al., "Role of Epigenetic Effectors in Maintenance of the Long-Term Persistent Bystander Effect in Spleen In Vivo," Carcinogenesis, 2007, pp. 1831-1838, vol. 28, No. 8. cited by applicant . Kozomara, A. et al., "miRBase: Integrating MicroRNA Annotation and Deep-Sequencing Data," Nucleic Acids Research, 2011, pp. D152-D157, vol. 39. cited by applicant . Krek, A. et al., "Combinatorial MicroRNA Target Predictions," Nature Genetics, May 2005, pp. 495-500, vol. 37, No. 5. cited by applicant . Kulshreshtha, R. et al., "A MicroRNA Signature of Hypoxia," Molecular and Cellular Biology, Mar. 2007, pp. 1859-1867, vol. 27, No. 5. cited by applicant . Kuroki, et al., "Genetic Alterations of the Tumor Suppressor Gene WWOX in Esophageal Squamous Cell Carcinoma," Cancer Research, Apr. 2002, pp. 2258-2260, vol. 62. cited by applicant . Kutay, H. et al., "Downregulation of miR-122 in the Rodent and Human Hepatocellular Carcinomas," Journal of Cellular Biochemistry, 2006, pp. 671-678, vol. 99. cited by applicant . Lagos-Quintana, M. et al., "Identification of Tissue-Specific MicroRNAs from Mouse," Current Biology, Apr. 2002, pp. 735-739, vol. 12. cited by applicant . Lagos-Quintana, M. et al., "New MicroRNAs From Mouse to Human," RNA, 2003, pp. 175-179, vol. 9, No. 2. cited by applicant . Landgraf, P. et al., "A Mammalian MicroRNA Expression Atlas Based on Small RNA Library Sequencing," Cell, Jun. 2007, pp. 1401-1414, vol. 129. cited by applicant . Landi, M. T. et al., "Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival," PLOS One, Feb. 2008, pp. 1-8, vol. 3, Issue 2. cited by applicant . Lanza, G. et al., "mRNA/microRNA Gene Expression Profile in Microsatellite Unstable Colorectal Cancer," Molecular Cancer, 2007, pp. 1-11, vol. 6, No. 54. cited by applicant . Lawrie, C.H. et al., "Detection of Elevated Levels of Tumour-Associated MicroRNAs in Serum of Patients with Diffuse Large B-Cell Lymphoma," British Journal of Haematology, 2008, pp. 672-675, vol. 141. cited by applicant . Lee, E. J. et al., "Expression Profiling Identifies MicroRNA Signature in Pancreatic Cancer," Int. J. Cancer, 2006, pp. 1046-1054, vol. 120. cited by applicant . Lewis, B. P. et al., "Prediction of Mammalian MicroRNA Targets," Cell, Dec. 2003, pp. 787-798, vol. 115. cited by applicant . Li, S.-C. et al., "Bioinformatic Discovery of MicroRNA Precursors from Human ESTs and Introns," BMC Genomics, 2006, vol. 7. cited by applicant . Li, Z. et al., "Inhibition of PRL-3 Gene Expression in Gastric Cancer Cell Line SGC7901 via MicroRNA Suppressed Reduces Peritoneal Metastasis," Biochemical and Biophysical Research, Sep. 2006, pp. 229-237, vol. 348, No. 1. cited by applicant . Lin, R.-K. et al., "Alteration of DNA Methyltransferases Contributes to 5'CpG Methylation and Poor Prognosis in Lung Cancer," Lung Cancer, 2007, pp. 205-213, vol. 55. cited by applicant . Lipp, E., "MicroRNAs Inform Cancer Research: Alterations in the Expression of miRNA Genes Contribute to Pathogenesis on Broad Basis," Genetic Engineering & Biotechnology News, Dec. 2009, pp. 38-39, genengnews.com. cited by applicant . Liu, C.-G. et al., "An Oligonucleotide Microchip for Genome-Wide MicroRNA Profiling in Human and Mouse Tissues," PNAS, Jun. 2004, pp. 9740-9744, vol. 101, No. 26. cited by applicant . Lu, J. et al., "MicroRNA Expression Profiles Classify Human Cancers," Nature, Jun. 2005, pp. 834-838, vol. 435. cited by applicant . Lu, J. et al., "MicroRNA Expression Profiles Classify Human Cancers," Nature, Jun. 2005, pp. 834-838, vol. 435, Supplementary Information. cited by applicant . Lujambio, A. et al., "A MicroRNA DNA Methylation Signature for Human Cancer Metastasis," PNAS, Sep. 2008, pp. 13556-13561, vol. 105, No. 36. cited by applicant . Ma, G. et al., "Expression of Programmed Cell Death 4 and Its Clinicopathological Significance in Human Pancreatic Cancer," Department of General Surgery, the First Affiliated Hospital, China Medical University, Oct. 2005, pp. 597-600. cited by applicant . Mack, G. S., "MicroRNA Gets Down to Business," Nature Biotechnology, Jun. 2007, pp. 631-638, vol. 25, No. 6. cited by applicant . Marchetti, A. et al., "EGFR Mutations in Non-Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening with Potential Implications on Pharmacologic Treatment," Journal of Clinical Oncology, Feb. 2005, pp. 857-865, vol. 23, No. 4. cited by applicant . Marcucci, et al., "MicroRNA Expression in Cytogenetically Normal Acute Myeloid Leukemia," NEJM, May 2008, pp. 1919-1928, vol. 358, No. 18. cited by applicant . Mattie, M. D. et al., "Optimized High-Throughput MicroRNA Expression Profiling Provides Novel Biomarker Assessment of Clinical Prostate and Breast Cancer Biopsies," Molecular Cancer, Jun. 2006, 14 pages, vol. 5, No. 24. cited by applicant . Mazurek, N. et al., "Phosphorylated Galectin-3 Mediates Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Signaling by Regulating Phosphatase and Tensin Homologue Deleted on Chromosome 10 in Human Breast Carcinoma Cells," The Journal of Biological Chemistry, Jul. 2007, pp. 21337-21348, vol. 282, No. 29. cited by applicant . McManus, M. T., "MicroRNAs and Cancer," Seminars in Cancer Biology, 2003, pp. 253-258, vol. 13. cited by applicant . Medina, P.P. et al., "OncomiR Addiction in an In Vivo Model of MicroRNA-21-Induced Pre-B-Cell Lymphoma," Nature Letters, Sep. 2010, pp. 86-91, vol. 467. cited by applicant . Medina, P.P., "OncomiR Addicton in an in vivo Model of Micro-RNA-21-Induced Pre-B-Cell Lymphoma," Supplementary Information, Sep. 2010, p. 1-22. cited by applicant . Megraw, M. et al., "miRGen: A Database for the Study of Animal MicroRNA Genomic Organization and Function," Nucleic Acids Research, 2007, pp. D149-D155, vol. 35. cited by applicant . Mendell, J.T., "miRiad Roles for the miR-17-92 Cluster in Development and Disease," Cell, 2008, pp. 217. cited by applicant . Meng, F. et al., "MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer," Gastroenterology, 2007, pp. 647-658, vol. 133. cited by applicant . Meng, F. et al., "Involvement of Human MicroRNA in Growth and Response to Chemotherapy in Human Cholangiocarcinoma Cell Lines," Gastroenterology, 2006, pp. 2113-2129, vol. 130. cited by applicant . Mi, S. et al., "MicroRNA Expression Signatures Accurately Discriminate Acute Lymphoblastic Leukemia from Acute Myeloid Leukemia," PNAS, Dec. 2007, pp. 19971-19976, vol. 104, No. 50. cited by applicant . Michael, M. Z. et al., "Reduced Accumulation of Specific MicroRNAs in Colorectal Neoplasia," Molecular Cancer Research, Oct. 2003, pp. 882-891, vol. 1. cited by applicant . Miller, M. K. et al., "Concurrent Chronic Lymphocytic Leukemia Cutis and Acute Myelogenous Leukemia Cutis in a Patient with Untreated CLL," The American Journal of Dermatopathology, 2001, pp. 334-340, vol. 23, No. 4. cited by applicant . Mitchell, P. S. et al., "Circulating MicroRNAs as Stable Blood-Based Markers for Cancer Detection," PNAS, Jul. 2008, pp. 10513-10518, vol. 105, No. 30. cited by applicant . Mitrovic, T. et al., "Cancer Gene Therapy," Arch. Oncology, 2005, pp. 23-26, vol. 13, No. 1. cited by applicant . Mountzios, G. et al., "Mechanisms of Disease: Signal Transduction in Lung Carcinogenesis-A Comparison of Smokers and Never-Smokers," Nature Clinical Practice Oncology, Oct. 2008, pp. 610-618, vol. 5, No. 10. cited by applicant . Murakami, Y. et al., "Comprehensive Analysis of MicroRNA Expression Patterns in Hepatocellular Carcinoma and Non-Tumorous Tissues," Oncogene, 2006 pp. 2537-2545, vol. 25., published online Dec. 5, 2005. cited by applicant . Naegeli, K. et al., "Novel Mechanisms of Ovarian Cancer Growth Inhibition, via MicroRNA Downregulation and Oxidative Damage, by a Ratioanlly Designed Histone Deacetylase Inhibitor," Abstract #2475, 98th ACCR Annual Meeting, Apr. 14-18, 2007, Los Angeles, CA. cited by applicant . Nakajima, G. et al., "Non-Coding MicroRNAs HAS-LET-7G and HAS-MIR-181b are Associated with Chemoresponse to S-1 in Colon Cancer," Cancer Genomics & Proteomics, Sep. 2006, pp. 317-324, vol. 3, No. 5. cited by applicant . Nakanishi, H. et al., "ALL1 Fusion Proteins Induce Deregulation of EphA7 and ERK Phosphorylation in Human Acute Leukemias," PNAS, Sep. 2007, pp. 14442-14447, vol. 104, No. 36. cited by applicant . Nam, E.J. et al., "MicroRNA Expression Profiles in Serous Ovarian Carcinoma," Clinical Cancer Research, 2008, pp. 2690-2695, vol. 14, No. 9. cited by applicant . Negrini, M. et al., "MicroRNAs in Human Cancer: From Research to Therapy," Journal of Cell Science, Apr. 2007, pp. 1833-1840, vol. 120. cited by applicant . Nicoloso, M.S. et al., "MicroRNAs--The Micro Steering Wheel of Tumour Metastases " Nature Reviews: Cancer, Apr. 2009, pp. 293-302, vol. 9. cited by applicant . Nurden, A.T., "Qualitative Disorders of Platelets and Megakaryocytes," Journal of Thrombosis and Haemostasis, 2005, vol. 3, pp. 1773-1782. cited by applicant . Okada, H. et al., "MicroRNAs in Immune Regulation--Opportunities for Cancer Immunotherapy," The International Journal of Biochemistry & Cell Biology, 2010, pp. 1256-1261, vol. 42. cited by applicant . Olivier, R.I. et al., "CA125 and Transvaginal Ultrasound Monitoring in High-Risk Women Cannot Prevent the Diagnosis of Advanced Ovarian Cancer," Gynecologic Oncology, 2006, pp. 20-26, vol. 100. cited by applicant . Palamarchuk, A. et al., "Akt Phosphorylates Tcl1 Oncoprotein and Inhibits Its Repressor Activity," Cancer Research, Jun. 2005, pp. 4515-4519, vol. 65, No. 11. cited by applicant . Pawelczyk, T. et al., "Expression in Escherichia coli and Simple Purification of Human Fhit Protein," Protein Expr. Purlf., Apr. 2000, pp. 320-326, vol. 18, No. 3. cited by applicant . Pedersen, I. M. et al., "Interferon Modulation of Cellular MicroRNAs as an Antiviral Mechanism," Nature, Oct. 2007, pp. 919-922, vol. 449. cited by applicant . Pekarsky, Y. et al., "Tcl1 Functions as a Transcriptional Regulator and is Directly Involved in the Pathogenesis of CLL," PNAS, Dec. 2008, pp. 19643-19648, vol. 105, No. 50. cited by applicant . Pekarsky, Y. et al., "Tcl1 Expression in Chronic Lymphocytic Leukemia is Regulated by miR-29 and miR-181," Cancer Research, Dec. 2006, pp. 11590-11593, vol. 66, No. 24. cited by applicant . Pekarsky, Y. et al., "Animal Models for Chronic Lymphocytic Leumekia," Journal of Cellular Biochemistry, 2007, pp. 1109-1118, vol. 100. cited by applicant . Pekarsky, Y. et al., "Tcl1 Enhances Akt Kinase Activity and Mediates Its Nuclear Translocation," PNAS, Mar. 2000, pp. 3028-3033, vol. 97, No. 7. cited by applicant . Petrocca, F. et al., "MicroRNAs Deregulation in Gastric Cancer," PNAS, Apr. 2006, p. 1338, vol. 47, Abstract # 5690. cited by applicant . Petrocca, F. et al., "E2F1-Regulated MicroRNAs Impair TGF.beta.-Dependent Cell-Cycle Arrest and Apoptosis in Gastric Cancer," Cancer Cell, Mar. 2008, pp. 272-286, vol. 13. cited by applicant . Pichiorri et al., "Downregulation of p53-Inducible MicroRNAs 192, 194 and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development," Cancer Cell, 2010, pp. 367-381, vol. 18. cited by applicant . Pichiorri, F. et al., "MicroRNAs Regulate Critical Genes Associated with Multiple Myeloma Pathogenesis," PNAS, Sep. 2008, pp. 12885-12890, vol. 105, No. 35. cited by applicant . Pineau, P. et al., "miR-221 Overexpression Contributes to Liver Tumorigenesis," PNAS, Jan. 2010, pp. 264-269, vol. 107, No. 1. cited by applicant . Porkka, K.P. et al., "MicroRNA Expression Profiling in Prostate Cancer," Cancer Research, 2007, pp. 6130-6135, vol. 67, No. 13. cited by applicant . Prueitt, R. L. et al., "Expression of MicroRNAs and Protein-Coding Genes Associated with Perineural Invasion in Prostate Cancer," The Prostate, 2008, pp. 1152-1164, vol. 68. cited by applicant . Pruitt, K.D. et al., "NCBI Reference Sequence (RefSeq): A Curated Non-Redundant Sequence Database of Genomes, Transcripts and Proteins," Nucleic Acids Research, 2005, pp. D501-D504, vol. 33. cited by applicant . Qin, H. R. et al., "A Role for the WWOX Gene in Prostate Cancer," Cancer Research, Jul. 2006, pp. 6477-6481, vol. 66, No. 13. cited by applicant . Ramkissoon, S. H, et al., "Hematopoietic-Specific MicroRNA Expression in Human Cells," Leukemia Research, 2006, pp. 643-647, vol. 30. cited by applicant . Ribas, J. et al., "The Transcriptional Regulation of miR-21, Its Multiple Transcripts, and Their Implication in Prostate Cancer," Cell Cycle, 2010, pp. 923-929, vol. 9. cited by applicant . Roldo, C. et al., "MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors Are Associated With Distinctive Pathologic Feature and Clinical Behavior," Journal of Clinical Oncology, Oct. 2006, pp. 4677-4684, vol. 24, No. 29. cited by applicant . Rossi, S. et al., "MicroRNA Fingerprinting of CLL Patients with Chromosome 17p Deletion Identify a miR-21 Score that Stratifies Early Survival," Blood, Aug. 2010, pp. 945-952, vol. 116, No. 6. cited by applicant . Rozovskaia, T. et al., "Expression Profiles of Acute Lymphoblastic and Myeloblastic Leukemias with ALL-1 Rearrangements," PNAS, Jun. 2003, pp. 7853-7858, vol. 100, No. 13. cited by applicant . Ryu, J.K. et al., "Aberrant MicroRNA-155 Expression is an Early Event in the Multistep Progression of Pancreatic Adenocarcinoma," Pancreatology, 2010, pp. 66-73, vol. 10. cited by applicant . Saini, H. K. et al., "Annotation of Mammalian Primary MicroRNAs," BMC Genomics, 2008, vol. 9. cited by applicant . Saito, Y. et al., "Specific Activation of MicroRNA-127 with Downregulation of the Proto-Oncogene BCL6 by Chromatin-Modifying Drugs in Human Cancer Cells," Cancer Cell, Jun. 2006, pp. 435-443, vol. 9. cited by applicant . Santanam, U. et al., "Chronic Lymphocytic Leukemia Modeled in Mouse by Targeted miR-29 Expression," PNAS, Jul. 2010, pp. 12210-12215, vol. 107, No. 27. cited by applicant . Sasaki, Y.T.F. et al., "Coordinated Expression of ncRNAs and HOX mRNAs in the Human HOXA Locus," Biochemical and Biophysical Communications, 2007, pp. 724-730, vol. 357. cited by applicant . Schagen, F. et al., "Genetic Targeting of Adenovirus Vectors Using a Reovirus Sigmal-Based Attachment Protein," Molecular Therapy, May 2006, pp. 997-1005, vol. 13, No. 5. cited by applicant . Schetter, A. J. et al., "MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma," JAMA, Jan. 2008, pp. 425-436, vol. 299, No. 4. cited by applicant . Schetter, A.J. et al., "Association of Inflammation-Related and MicroRNA Gene Expression with Cancer Specific Mortality of Colon Adenocarcinoma," Clin. Cancer Res., Sep. 2009, pp. 5878-5887, vol. 15, No. 18. cited by applicant . Schmittgen, T. D. et al., "A High-Throughput Method to Monitor the Expression of MicroRNA Precursors," Nucleic Acids Research, Feb. 2004, vol. 32, No. 4. cited by applicant . Seike, M. et al., "MiR-21 is an EGFR-Regulated Anti-Apoptotic Factor in Lung Cancer in Never-Smokers," PNAS, Jul. 2009, pp. 12085-12090. vol. 106, No. 29. cited by applicant . Seike, M. et al., "MiR-21 is an EGFR-Regulated Anti-Apoptotic Factor in Lung Cancer in Never-Smokers," Supporting Information, PNAS, Jul. 2009, pp. 12085-12090. vol. 106, No. 29. cited by applicant . Seike, M., "MicroRNA Expression Profiles in Lung Cancer Cooperated with Drug Sensitivity to EGFR Tyrosine Kinase Inhibitor," J. Nippon Med. School, 2009, pp. 275-276, vol. 76, No. 5. cited by applicant . Seth, P., "Vector-Mediated Cancer Gene Therapy," Cancer Biology & Therapy, May 2005, pp. 512-517, vol. 4, Issue 5. cited by applicant . Sevinsky, J. R. et al., "Extracellular Signal-Regulated Kinase Induces the Megakaryocyte GPllb/CD41 Gene Through MafB/Kreisler," Molecular and Cellular Biology, May 2004, pp. 4534-4545, vol. 24, No. 10. cited by applicant . Sharma, S. et al., "Development of Inhalational Agents for Oncologic Use," Journal of Clinical Oncology, Mar. 2001, Abstract, vol. 19, Issue 6. cited by applicant . Shen, H, et al., "A Novel Polymorphism in Human Cytosine DNA-Methyltransferase-3B Promoter is Associated with an Increased Risk of Lung Cancer," Cancer Research, Sep. 2002, pp. 4992-4995, vol. 62. cited by applicant . Slack, F.J., "Big Roles for Small RNAs," Nature, Feb. 2010, p. 616, vol. 463. cited by applicant . Stamatopoulos, B. et al., "MicroRNA-29c and MicroRNA-233 Down-Regulation has In Vivo Significance in Chronic Lymphocytic Leukemia and Improves Disease Risk Stratification," Blood, May 2009, pp. 5237-5245, vol. 113, No. 21. cited by applicant . Suarez-Saiz, F.J. et al., "MicroRNA Expression Profiling in Acute Myelogenous Leukemia," Canada Blood, Nov. 2004, Abstract #1131, p. 320A. cited by applicant . Taccioli, C. et al., "Ucbase & miRfunc: A Database of Ultraconserved Sequences and MicroRNA Function," Nucleic Acids Research, 2009, pp. D41-D48, vol. 37. cited by applicant . Takamizawa, J. et al., "Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival," Cancer Research, Jun. 2004, pp. 3753-3756, vol. 64. cited by applicant . Tang, X. et al., "A Simple Array Platform for MicroRNA Analysis and Its Application in Mouse Tissues," RNA, Aug. 2007, pp. 1-20, vol. 13. cited by applicant . Taylor, D.D. et al., "MicroRNA Signatures of Tumor-Derived Exosomes as Diagnostic Biomarkers of Ovarian Cancer," Gynecologic Oncology, 2008, pp. 13-21, vol. 110. cited by applicant . Thomson, J. M. et al., "A Custom Microarray Platform for Analysis of MicroRNA Gene Expression," Nature Methods, Oct. 2004, pp. 1-7, vol. 1, No. 1. cited by applicant . Thomson, M., Supplementary data for "A Custon Microarray Platform for Analysis of MicroRNA Gene Expression," Nature Methods, Oct. 2004, pp. 47-53, vol. 1, No. 1. cited by applicant . Thorgeirsson, S. S. et al., "Functional Genomics of Hepatocellular Carcinoma," Hepatology, Feb. 2006, pp. S145-S150, vol. 43, No. 2, Suppl. 1. cited by applicant . Tili, E. et al., "Expression and Function of Micro RNAs in Immune Cells During Normal or Disease State," International Journal of Medicine Sciences, 2008, pp. 73-79, vol. 5, No. 2. cited by applicant . Tockman, M. S. et al., "Considerations in Bringing a Cancer Biomarker to Clinical Application," Cancer Research, May 1992, pp. 2711s-2718s, vol. 52. cited by applicant . Trapasso, F. et al., "Fhit Interaction with Ferredoxin Reductase Triggers Generation of Reactive Oxygen Species and Apoptosis of Cancer Cells," Journal of Biological Chemistry, May 2008, pp. 13736-13744, vol. 283, No. 20. cited by applicant . Tricoli, J. V. et al., "MicroRNA: Potential for Cancer Detection, Diagnosis, and Prognosis," Cancer Research, May 2007, pp. 4553-4555, vol. 67, No. 10. cited by applicant . Ueda, T. et al., "Relation Between MicroRNA Expression and Progression and Prognosis of Gastric Cancer: A MicroRNA Expression Analysis," Published Online; www.thelancet.com/oncology, Dec. 2009, DO1:10.1016/S1470-2045(09)70343-2. cited by applicant . Uil, T.G. et al., "Generation of an Adenoviral Vector Containing an Addition of a Heterologous Ligand to the Serotpe 3 Fiber Knob," Cancer Gene Therapy, Feb. 2003, pp. 121-124, vol. 10, No. 2. cited by applicant . Valeri, N. et al., "Epigenetics, miRNAs, and Human Cancer: A New Chapter in Human Gene Regulation," Mamm Genome, Aug. 2009, pp. 573-580, vol. 20. cited by applicant . Valeri, N. et al., "Modulation of Mismatch Repair and Genomic Stability by miR-155," PNAS, Apr. 2010, pp. 6982-6987, vol. 107, No. 15. cited by applicant . Varnholt, H. et al., "MicroRNA Gene Expression Profile of Hepatitis C Virus-Associated Hepatocellular Carcinoma," Hepatology, Apr. 2008, pp. 1223-1232, Vo. 47, No. 4. cited by applicant . Vassilev et al., "In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2," Science, 2004, pp. 844-848, vol. 303. cited by applicant . Verschuur, A.C., "Acute Megakaryoblastic Leukemia," May 2004, pp. 1-5, Retrieved from the Internet: URL:http://www.orpga.net/data/patho/GB/uk-AMLM7.pdf. cited by applicant . Virgilio, L. et al., "Identification of the TCL1 Gene Involved in T-Call Malignancies," Proc. Natl. Acad. Sci., Dec. 1994, pp. 12530-12534, vol. 91. cited by applicant . Visone, R. et al., "MiRNAs and Cancer," The American Journal of Pathology, Apr. 2009, pp. 1131-1138, vol. 174, No. 4. cited by applicant . Volinia, et al., "Reprogramming of MirRNA Networks in Cancer and Leukemia," Genome Research, 2010, pp. 589-599, vol. 20. cited by applicant . Volinia, S. et al., "A MicroRNA Expression Signature of Human Solid Tumors Defines Cancer Gene Targets," PNAS, Feb. 2006, pp. 2257-2261, vol. 103, No. 7. cited by applicant . Wang, E. et al., "Ontogeny and Oncogenesis Balance the Transcriptional Profile of Renal Cell Cancer," Cancer Research, Oct. 2004, pp. 7279-7287, vol. 64. cited by applicant . Wang, X. et al., "Association Between CpG Island Methylation of the WWOX Gene and Its Expression in Breast Cancers," Tumor Biology, Feb. 2009, pp. 8-14, vol. 30. cited by applicant . Watson, D.I. et al., "MicroRNA Expression Profiles in Barrett's Oesophagus," RACS Annual Scientific Congress, 2007, pp. A45, vol. 77. cited by applicant . Weidhaas, J., "Using MicroRNAs to Understand Cancer Biology," Published Online Dec. 21, 2009, DOI: 10.1016/S1470-2045(09)70386-9. cited by applicant . Wiemer et al., "The Role of MicroRNAs in Cancer: No Small Matter," European Journal of Cancer, Jun. 12, 2007, vol. 43, No. 10, pp. 1529-1544. cited by applicant . Wijermans, P.W., "Low Dose Azanucleosidesfor High Risk (s) MDS and AML," Haematologica Reports,Nov. 2006, pp. 74-76. vol. 2, Issue, 15. cited by applicant . Xi, Y. et al., "Prognostic Values of MicroRNAs in Colorectal Cancer," Biomarker Insights, Jan. 2006, pp. 113-121, vol. 1. cited by applicant . Yamashita, T. et al., "EpCAM and .alpha.-Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma," Cancer Research, Mar. 2008, pp. 1451-1461, vol. 68, No. 5. cited by applicant . Yamashita, T. et al., "Activation of Hepatic Stem Cell Marker EpCAM by Wnt-.beta.-Catenin Signaling in Hepatocellular Carcinoma," Cancer Research, Nov. 2007, pp. 10831-10839, vol. 67, No. 22. cited by applicant . Yanaihara, N. et al., "Unique MicroRNA Molecular Profiles in Lung Cancer Diagnosis and Prognosis," Cancer Cell, Mar. 2006, pp. 189-198, vol. 9. cited by applicant . Yang, J. et al., "Analysis of Sequence Variations in 59 MicroRNAs in Hepatocellular Carcinomas," Mutation Research, Aug. 2008, pp. 205-209, vol. 638. cited by applicant . Yendamuri, S. et al., "WW Domain Containing Oxidoreductase Gene Expression is Altered in Non-Small Cell Lung Cancer," Cancer Research, Feb. 2003, pp. 878-881, vol. 63. cited by applicant . Yoon, S. et al., "Prediction of Regulatory Modules Comprising MicroRNAs and Target Genes," Bioinformatics Genes and Genomes, 2005. pp. ii93-ii100, vol. 21, Suppl. 2. cited by applicant . Yu, L.-G. et al., "Protein Phosphatase 2A, a Negative Regulator of the ERK Signaling Pathway, Is Activated by Tyrosine Phosphorylation of Putative HLA Class II-Associated Protein I (PHAPI)/pp32 in Response to the Antiproliferative Lectin, Jacalin," The Journal of Biological Chemisty, Jul. 2004, pp. 41377-41383, vol. 279, No. 40. cited by applicant . Zawacka-Pankau, J. et al., "Expression and Simple, One-Step Purification of Fragile Histidine Triad (Fhit) Tumor Suppressor Mutant Forms in Escherichia coli and their Interaction with Protoporphyrin IX," Biotechnology Letters, Jun. 2007, pp. 877-883, vol. 29, No. 6. cited by applicant . Zeng, Y. et al., "Recognition and Cleavage of Primary MicroRNA Precursors by the Nuclear Processing Enzyme Drosha," The EMBO Journal, 2005, pp. 138-148, vol. 24. cited by applicant . Zhang, L. et al., "Genomic and Epigenetic Alterations Deregulate MicroRNA Expression in Human Epithelial Ovarian Cancer," PNAS, May 2008, pp. 7004-7009, vol. 105, No. 19. cited by applicant . Zhang, L. et al., "MicroRNAs Exhibit High Frequency Genomic Alterations in Human Cancer," PNAS, Jun. 2006, pp. 9136-9141, vol. 103, No. 24. cited by applicant . Zhang, L. et al., Supporting Information, PNAS 2008, pp. 1-11. cited by applicant . Zhang, Z. et al., "Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer," Cancer Research, Aug. 2004, pp. 5882-5890, vol. 64. cited by applicant . Zhao et al., "p53 Mediates the Negative Regulation of MDM2 by Orphan Receptor TR3," The EMBO Journal, 2006, pp. 5703-5715, vol. 25. cited by applicant . Zhu, S. et al., "MicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM 1)," Journal of Biological Chemistry, May 2007, pp. 14328-14336, vol. 282, No. 19. cited by applicant. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.